BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hepatitis
,
Stem cell
,
Autoimmunity
,
Vitamin E
,
rs2230926
,
MYC
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
carotid body tumor
Summary
General Info
Curated Studies
Most Correlated Studies
Brain tissues from ADRB2 knockout mice in a model of artery occlusion induced stroke
OMIM - Paraganglioma
Human umbilical vein endothelial cells with ADAR siRNA knockdown cultured in normoxia or hypoxia
Explore Curated Studies Results
Literature
Most Relevant Literature
Rare and complicated functional posterior mediastinal paraganglioma.
An Incidental Uptake of 18F-Choline in Paraganglioma.
18 F-FDOPA PET/CT of Paraganglioma in the Spermatic Cord.
Is Nuclear Imaging Important in the Management of Head and Neck Paragangliomas?
Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Endovascular Carotid Body Ablation in Patients With Treatment- Resistant Hypertension: A Safety and …
Safety Study of Carotid Body Neurostimulation to Treat Cerebral Vasospasm
Carotid Revascularization Versus Best Medical Treatment for Asymptomatic Carotid Stenosis
Endarterectomy vs Stenting in Chinese Asymptomatic Carotid Stenosis Patients
Radial Versus Femoral Access For Carotid Artery Stenting
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ